| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/2010 | US20100184852 Organic compounds for treatment of disorders connected to impaired neurotransmission |
| 07/22/2010 | US20100184851 Inhibition of cell proliferation |
| 07/22/2010 | US20100184850 Phenolic extracts of almond peel containing procyanidins, propelargonidins, and prodelphinidins, and method for preparation thereof |
| 07/22/2010 | US20100184849 Urea oligomers, their preparation process and pharmaceutical compositions containing them |
| 07/22/2010 | US20100184848 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 07/22/2010 | US20100184847 Compositions for skin protection and improvement of skin diseases containing the dibenzo-p-dioxine derivatives |
| 07/22/2010 | US20100184846 Methods for the formulation and manufacture of artesunic acid for injection |
| 07/22/2010 | US20100184845 Myeloid Colony Stimulating Factor and Uses Thereof |
| 07/22/2010 | US20100184843 Identification of a pin specific gene and protein (pin-1) useful as a diagnostic treatment for prostate cancer |
| 07/22/2010 | US20100184842 Ultraconserved Regions Encoding ncRNAs |
| 07/22/2010 | US20100184841 Extended dicer substrate agents and methods for the specific inhibition of gene expression |
| 07/22/2010 | US20100184840 Primary micro rna expression cassette |
| 07/22/2010 | US20100184839 Allelic polymorphism associated with diabetes |
| 07/22/2010 | US20100184838 Compositions and methods for retinal transduction and photoreceptor specific transgene expression |
| 07/22/2010 | US20100184837 Small-molecule nucleotide aptamer for hepatitis C virus, preparation method and use thereof |
| 07/22/2010 | US20100184836 Vaccine |
| 07/22/2010 | US20100184835 Devices, Systems and Methods for Improving Memory and/or Cognitive Function Through Brain Delivery of Sirna |
| 07/22/2010 | US20100184834 Immunostimulatory sequence oligonucleotides and methods of using the same |
| 07/22/2010 | US20100184833 Methods and means for treating dna repeat instability associated genetic disorders |
| 07/22/2010 | US20100184832 Construction of Recombinant Virus Vaccines by Direct Transposon-Mediated Insertion of Foreign Immunologic Determinants into Vector Virus Proteins |
| 07/22/2010 | US20100184830 Compositions and Methods for the Diagnosis and Therapy of BCL2-Associated Cancers |
| 07/22/2010 | US20100184829 Rnai modulation of scap and therapeutic uses thereof |
| 07/22/2010 | US20100184828 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184827 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184826 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 07/22/2010 | US20100184824 RNA Interference Mediated Inhibition of Interleukin and Interleukin Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 07/22/2010 | US20100184823 dsRNA For Treating Viral Infection |
| 07/22/2010 | US20100184822 Method of modulating the activity of a nucleic acid molecule |
| 07/22/2010 | US20100184821 Compositions and Methods for Modulating Angiogenesis |
| 07/22/2010 | US20100184820 Combinations comprising staurosporines |
| 07/22/2010 | US20100184819 Method for reducing intracranial pressure |
| 07/22/2010 | US20100184818 Photosensitizers for targeted photodynamic therapy |
| 07/22/2010 | US20100184817 Methods of treating neuropathy |
| 07/22/2010 | US20100184815 Agonists of peroxisome proliferator activated receptor-alpha |
| 07/22/2010 | US20100184814 Ester Derivatives of Losartan, Methods for Their Preparation, and Uses Thereof |
| 07/22/2010 | US20100184813 Chemical compounds 553 |
| 07/22/2010 | US20100184812 Mutual prodrugs and methods to treat cancer |
| 07/22/2010 | US20100184811 Isoniazid mediated healing of wounds and ulcers |
| 07/22/2010 | US20100184810 Methods and compositions related to riboswitches that control alternative splicing |
| 07/22/2010 | US20100184809 Heterocyclic FXR Binding Compounds |
| 07/22/2010 | US20100184808 3-aza-bicyclo[3.3.0]octane compounds |
| 07/22/2010 | US20100184807 Methods to inhibit tumor cell growth by using proton pump inhibitors |
| 07/22/2010 | US20100184806 Modulation of neurogenesis by ppar agents |
| 07/22/2010 | US20100184805 Renin inhibitors |
| 07/22/2010 | US20100184804 Methods for the prevention or treatment of bacterial and fungal infections |
| 07/22/2010 | US20100184803 Treatment of Lysosomal Storage Diseases |
| 07/22/2010 | US20100184802 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 07/22/2010 | US20100184801 Fused amino pyridines for the treatment of brain tumors |
| 07/22/2010 | US20100184800 Compounds for the Treatment of Hepatitis C |
| 07/22/2010 | US20100184799 Oxadiazole beta carboline derivatives as antidiabetic compounds |
| 07/22/2010 | US20100184798 Methods to Predict Cholesterol Elevations during Immunosuppressant Therapy |
| 07/22/2010 | US20100184797 Treatment of dyskinesia |
| 07/22/2010 | US20100184795 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same |
| 07/22/2010 | US20100184794 Fused heterocyclic compound |
| 07/22/2010 | US20100184793 Compositions incorporating sesamin-class compounds and vitamin b1 class compounds |
| 07/22/2010 | US20100184791 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/22/2010 | US20100184790 Pyrrolo[2,3-b]pyridine compounds, azaindole compounds used for synthesizing said pyrrolo[2,3-b]pyridine compounds, methods for the production thereof, and uses thereof |
| 07/22/2010 | US20100184789 Inhibitors of protein kinases |
| 07/22/2010 | US20100184788 Heterocyclic derivatives |
| 07/22/2010 | US20100184787 Heataryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 07/22/2010 | US20100184786 Polar Quinazolines |
| 07/22/2010 | US20100184785 Pharmaceutical formulation for the production of chewable tablets and lozenges |
| 07/22/2010 | US20100184784 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 07/22/2010 | US20100184783 Combination for use in the treatment of inflammatory atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist |
| 07/22/2010 | US20100184782 Fused bicyclic pyrimidines |
| 07/22/2010 | US20100184781 Fxa inhibitors with cyclic amidines as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof |
| 07/22/2010 | US20100184780 Inhibitors of protein kinases |
| 07/22/2010 | US20100184779 Method for optimizing the treatment of chronic myeloid leukemia with abl tyrosine kinase inhibitors |
| 07/22/2010 | US20100184778 Novel heterocycle compounds and uses thereof |
| 07/22/2010 | US20100184777 Substituted Pyrazinone Amides |
| 07/22/2010 | US20100184776 Piperidine/piperazine derivatives |
| 07/22/2010 | US20100184775 Organic compounds |
| 07/22/2010 | US20100184774 Methods of treatment |
| 07/22/2010 | US20100184773 Germline Polymorphisms in the Angiogenic Pathway Predict Tumor Recurrence in Cancer Therapy |
| 07/22/2010 | US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2010 | US20100184771 Bicyclic Heterocyclic Compound |
| 07/22/2010 | US20100184770 Compounds |
| 07/22/2010 | US20100184769 Pde inhibitors for the treatment of hearing impairment |
| 07/22/2010 | US20100184768 Isoprenyl Compounds and Methods Thereof |
| 07/22/2010 | US20100184767 Substituted oxazolidinones and use thereof |
| 07/22/2010 | US20100184766 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | US20100184765 Protein Kinase Inhibitors and Methods for Using Thereof |
| 07/22/2010 | US20100184764 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/22/2010 | US20100184763 Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 07/22/2010 | US20100184762 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 07/22/2010 | US20100184761 6-PHENYL-1H-IMIDAZO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES |
| 07/22/2010 | US20100184760 Benzoxazole kinase inhibitors and methods of use |
| 07/22/2010 | US20100184759 Pyrano-pyrazole-amines |
| 07/22/2010 | US20100184758 Beta carboline derivatives as antidiabetic compounds |
| 07/22/2010 | US20100184757 Fungicidally active compound combinations |
| 07/22/2010 | US20100184755 Protein kinase c inhibitors and uses thereof |
| 07/22/2010 | US20100184754 Quinolinone derivatives |
| 07/22/2010 | US20100184753 Ion Channel Modulators and Methods of Uses |
| 07/22/2010 | US20100184752 Phenothiazine compounds for treating mild cognitive impairment |
| 07/22/2010 | US20100184751 Heterocyclic compounds for the treatment of tuberculosis |
| 07/22/2010 | US20100184750 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | US20100184749 Benzothiadiazine compounds and their use |
| 07/22/2010 | US20100184748 Compounds and compositions as itpkb inhibitors |
| 07/22/2010 | US20100184747 Indoline derivatives and their use in treating disease-states such as cancer |